DocGo, Inc - DCGO Enterprise Value to EBITDA Ratio
DocGo Inc. (DCGO) generates revenue through emergency patient transport and mobile medical treatment under government contracts. The brand's high authority among hospitals is driven by tech-enabled dispatch management and the rapid response of its teams. The current EV/EBITDA ratio stands at 0.00, which is reflected in the current market quotes visualized below, while the business remains fully insulated from external sanctions by operating exclusively within the US.
Summary analytical data breakdowns for docgo.com (DCGO)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
DCGO - Net Financial Result|Expected Profit DocGo Inc.|DCGO - Price to Earnings Multiple|Forward P/E Multiple DocGo Inc.|DCGO - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio DocGo, Inc|DCGO - Operating income before deduction of amortization|Net earnings per share (EPS TTM) DocGo|DCGO - Earnings per share for the last 12 months|Quarterly EPS earnings growth docgo.com|DCGO - Net earnings per share growth this year|Earnings growth forecast for next year DocGo Inc.
Basic company analysis:DCGO (DocGo Inc)
DocGo Inc. is transforming its municipal contract service model toward diversified B2B retail. The business valuation via EV/EBITDA dynamically compares the company's total enterprise value, including debt, against its operational profitability before taxes. The indicator's current trajectory reflects the market value of assets relative to the ability to generate cash flow. Investors utilize this multiple to determine position liquidity and analyze business contraction risks.
Competitor analysis
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|EHC: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation UHS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DaVita Inc|Company Value to EBITDA RadNet Management RDNT|EV/EBITDA Multiple OPCH|Enterprise Value to EBITDA Ratio surgerypartners.com SGRY|EV/EBITDA Multiple PINC (Premier)|Enterprise Value to EBITDA Multiple National Vision Holdings, Inc.|PGNY - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Ardent Health Corp|SEM (Select Medical) - Enterprise Value to EBITDA Ratio|astranahealth.com - Business Value to Operating Income Before Depreciation|MD (Pediatrix) - EV/EBITDA Multiple|US Physical Therapy Inc (USPH) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pennant Group Inc (PNTG)|Organogenesis Corp - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple NUTX (Nutex Health Inc.)|AUNA - Enterprise Value to EBITDA Ratio|SBC: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Evolus Inc EOLS|CYH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation SKIN|MDWD (MediWound Ltd) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio biote.com (BTMD)|EV/EBITDA Multiple JYNT|p3hp.org (PIII) - Enterprise Value to EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Gain Therapeutics, Inc. GANX|euda.com (EUDA) - Company Value to EBITDA|BMGL: Enterprise Value to EBITDA Ratio|CollPlant Biotechnologies - Enterprise Value to Operating Income Before Depreciation Ratio|Cuprina Holdings (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Concord Medical Services Holdings - Business Value to Operating Income Before Depreciation|AMS (American Shared Hospital Services, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA MEDIROM Corp MRM|EV/EBITDA Multiple ALBT|EV/EBITDA Multiple dih.com (DHAI)|Carmell Therapeutics - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NIVF (NewGenIvf Group)|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CareMax, Inc (CMAX) - Enterprise Value to EBITDA Ratio|KDLY: EV/EBITDA Multiple|Company Value to EBITDA modivcare.com (MODV)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Novo Integrated Sciences, Inc.|Enterprise Value to Operating Income Before Depreciation SSY (SunLink Health Systems, Inc)|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)
